Feihu Wang
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Supramolecular Self-Assembly in Materials
- Drug Discovery top 2%
Papers in
- Biomaterials 28
- Nanoparticle-Based Drug Delivery 15
- Supramolecular Self-Assembly in Materials 15
- Co-authors
- Honggang Cui (19 shared papers)Shengrong Guo (19 shared papers)Hao Su (13 shared papers)Yun Wang (7 shared papers)Wenjun Zhang (4 shared papers)Mikhail E. Itkis (11 shared papers)Robert C. Haddon (10 shared papers)Elena B. Bekyarova (10 shared papers)
- Journals
- Journal of the American Chemical Society (7 papers)Journal of Controlled Release (6 papers)ACS Nano (4 papers)Acta Biomaterialia (3 papers)Acta Pharmaceutica Sinica B (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Feihu Wang
61 papers receiving 3k citations
Peers
Comparison fields: 5 of 90
- Biomaterials 1.3k
- Drug Discovery 20
- Molecular Medicine 308
- Pharmaceutical Science 143
- Biomedical Engineering 522
Countries citing papers authored by Feihu Wang
This map shows the geographic impact of Feihu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feihu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feihu Wang more than expected).
Fields of papers citing papers by Feihu Wang
This network shows the impact of papers produced by Feihu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feihu Wang. The network helps show where Feihu Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Feihu Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 343 | |
| 2 | 2020 | 286 | |
| 3 | 2012 | 167 | |
| 4 | 2017 | 165 | |
| 5 | 2020 | 139 | |
| 6 | 2016 | 134 | |
| 7 | 2016 | 130 | |
| 8 | 2020 | 110 | |
| 9 | 2020 | 100 | |
| 10 | 2013 | 84 | |
| 11 | 2019 | 77 | |
| 12 | 2016 | 75 | |
| 13 | 2020 | 74 | |
| 14 | 2018 | 70 | |
| 15 | 2019 | 69 | |
| 16 | 2023 | 62 | |
| 17 | 2014 | 61 | |
| 18 | 2022 | 58 | |
| 19 | 2014 | 55 | |
| 20 | 2015 | 54 |
About Feihu Wang
Feihu Wang is a scholar working on Biomaterials, Molecular Medicine, Materials Chemistry, Immunology and Biomedical Engineering, having authored 63 papers that have together received 3.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (15 papers), Supramolecular Self-Assembly in Materials (15 papers), Nanoplatforms for cancer theranostics (9 papers), Graphene research and applications (8 papers), Carbon Nanotubes in Composites (6 papers), Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and RNA Interference and Gene Delivery (5 papers). The work is most often cited by research in Biomaterials (1.3k citations), Drug Discovery (20 citations), Molecular Medicine (308 citations), Pharmaceutical Science (143 citations) and Biomedical Engineering (522 citations). Feihu Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Honggang Cui, Shengrong Guo, Hao Su, Yun Wang, Wenjun Zhang, Mikhail E. Itkis, Robert C. Haddon, Elena B. Bekyarova, Caleb F. Anderson and Yuanyuan Shen. Their work appears in journals such as Journal of the American Chemical Society, Journal of Controlled Release, ACS Nano, Acta Biomaterialia and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.